Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hetlioz
Pharma
Vanda, FDA reach 'collaborative framework' after disputes
The FDA agreed to re-review Vanda's previously rejected bid to market its Hetlioz in jet lag disorder after years of legal back-and-forth on the matter.
Zoey Becker
Oct 2, 2025 11:10am
Vanda touts 'landmark' win over FDA in yearslong dispute
Aug 18, 2025 11:25am
Vanda sues FDA for right to promote off-label drug use
Apr 11, 2025 1:53pm
Cycle's 2nd hostile takeover bid in 5 months rejected by Vanda
Oct 14, 2024 3:18pm
Vanda gets $466M takeout bid from Cycle Pharma
Jun 6, 2024 10:10am
Supreme Court rejects Vanda's Hetlioz patent revival appeal
Apr 22, 2024 3:49pm
